Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pedro Isaacsson Velho, M,D
Moinhos de Vento Hospital
Principal Investigator - Samuel Denmeade, M,D
Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Moinhos de Vento Hospital
Porto Alegre, Brazil
Not, yet, recruiting
- Amber Michalik
Baltimore, Maryland, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Apr 2022
- Primary completion
- 29 Feb 2028
- Completion
- 28 Feb 2029
- Last update posted
- 6 Feb 2026
- Registered enrollment
- 47
- Registry id
- NCT04704505
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.